USDA approves new canine cancer therapy
ELIAS Cancer Immunotherapy is an adoptive cell therapy treatment for canine osteosarcoma
Read More
Eye to eye: Navigating ophthalmology emergencies
Alex Sigmund, DVM, DACVO, shares his expertise on dealing with ocular emergencies on this episode of The Vet Blast Podcast presented by dvm360.
Listen
Managing cancer in general practice
Rachel Venable, DVM, MS, DACVIM (Oncology) discussed what primary doctors can do to treat their patients with cancer when clients decline specialty care during a WVC 2025 CE session
Kicking off National Pet Cancer Awareness Month
Sue Ettinger, DVM, DACVIM (Oncology), discusses the importance of cancer awareness with Adam Christman, DVM, MBA, in recognition of National Pet Cancer Awareness Month
Managing canine oral tumors
The type of lesion will guide treatment and prognosis
Laverdia-CA1's field trial ends, statistical analysis to begin
Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the drug closer to approval
